You are here

drug pricing

Under pressure, drugmakers dilute price hikes, but nothing is set in stone just yet — report

Under pressure, drugmakers dilute price hikes, but nothing is set in stone just yet — report

Endpoints

Flag link:

Senate bill could give HHS teeth to stop excessive drug price hikes

Senate bill could give HHS teeth to stop excessive drug price hikes

BioCentury

Flag link:

BIO chair: More drugmakers should pledge to not hike prices

BIO chair: More drugmakers should pledge to not hike prices

BioPharma Dive

Flag link:

Senator to Pfizer CEO: Stop playing 'political games' with drug prices

Senator to Pfizer CEO: Stop playing 'political games' with drug prices

Fierce Pharma

Flag link:

Gottlieb blasts high insulin prices, touts far-off new rules he says will spur competition in that market

Gottlieb blasts high insulin prices, touts far-off new rules he says will spur competition in that market

Stat

Flag link:

Democrats are suddenly eyeing a valuable pharma asset: its patents

Democrats are suddenly eyeing a valuable pharma asset: its patents

Stat

Flag link:

How Perceptions of High Drug Prices Do Not Necessarily Match Reality

How Perceptions of High Drug Prices Do Not Necessarily Match Reality

BioSpace

Flag link:

What do Martin Shkreli, Gilead and Takeda have in common? They all figure prominently in the new top-20 list of the world’s most expensive drugs

What do Martin Shkreli, Gilead and Takeda have in common? They all figure prominently in the new top-20 list of the world’s most expensive drugs

Endpoints

Gilead Sciences

Flag link:

With new drug pricing legislation, Grassley, Wyden hint at the next steps for a powerful Senate committee

With new drug pricing legislation, Grassley, Wyden hint at the next steps for a powerful Senate committee

Stat

Flag link:

Generic Drug Prices ‘Strongly Predictive’ of Shortages, Study Finds

Generic Drug Prices ‘Strongly Predictive’ of Shortages, Study Finds

RAPS.org

Flag link:

Spotlight on drug pricing could be catalyst for change in US biosimilar landscape

Spotlight on drug pricing could be catalyst for change in US biosimilar landscape

Endpoints

Flag link:

Merck increased list prices on Keytruda, Gardasil in November

Merck increased list prices on Keytruda, Gardasil in November

Biopharma Dive

Flag link:

US benefits manager baulks after Novartis values gene therapy at $4-5 mln

US benefits manager baulks after Novartis values gene therapy at $4-5 mln

Yahoo/Reuters

Express Scripts

spinal muscular atrophy

Flag link:

As power shifts hands in Washington, a top analyst predicts an unavoidable war over rising drug prices

As power shifts hands in Washington, a top analyst predicts an unavoidable war over rising drug prices

Endpoints

Flag link:

A drug maker boosted the price of its opioid-overdose antidote by 600 percent, and taxpayers suffered

A drug maker boosted the price of its opioid-overdose antidote by 600 percent, and taxpayers suffered

Stat

opioid addiction

Flag link:

Pfizer tests Trump with plans to hike prices on 41 drugs

Pfizer tests Trump with plans to hike prices on 41 drugs

Biopharma Dive

Flag link:

How Pharmacists Are Trapped in the Middle of Drug Price Wars

How Pharmacists Are Trapped in the Middle of Drug Price Wars

Drug Patent Watch

Flag link:

5 election takeaways for pharma

5 election takeaways for pharma

Biopharma Dive

Flag link:

Sage depression drug to cost between $20K and $35K, if approved

Sage depression drug to cost between $20K and $35K, if approved

Biopharma Dive

SAGE Therapeutics

postpartum depression

Flag link:

Democrats vow to tackle drug prices after midterm victory

Democrats vow to tackle drug prices after midterm victory

Pharmaforum

Flag link:

Pages